vs
Side-by-side financial comparison of Beta Bionics, Inc. (BBNX) and Maison Solutions Inc. (MSS). Click either name above to swap in a different company.
Beta Bionics, Inc. is the larger business by last-quarter revenue ($27.6M vs $27.6M, roughly 1.0× Maison Solutions Inc.). Maison Solutions Inc. runs the higher net margin — -18.0% vs -79.3%, a 61.3% gap on every dollar of revenue. On growth, Beta Bionics, Inc. posted the faster year-over-year revenue change (56.6% vs -10.9%).
Beta Bionics, Inc. is a medical technology company focused on developing and commercializing advanced automated diabetes management solutions. Its core product is the iLet Bionic Pancreas, a wearable device that automatically adjusts insulin and glucagon delivery for people with Type 1 and Type 2 diabetes, serving primarily the U.S. healthcare market with plans for global expansion.
Maison Solutions Inc.MSSEarnings & Financial Report
Maison Solutions Inc. is a specialty home goods retail company that provides a diverse portfolio of stylish, affordably priced furniture, home decor items, and daily household products. Its primary market is the Guangdong-Hong Kong-Macao Greater Bay Area in China, serving mass consumers through both offline physical stores and online e-commerce channels.
BBNX vs MSS — Head-to-Head
Income Statement — Q1 FY2026 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $27.6M | $27.6M |
| Net Profit | $-21.9M | $-5.0M |
| Gross Margin | 59.5% | 23.4% |
| Operating Margin | -47.4% | -4.9% |
| Net Margin | -79.3% | -18.0% |
| Revenue YoY | 56.6% | -10.9% |
| Net Profit YoY | 23.6% | -1840.5% |
| EPS (diluted) | $-0.49 | $-0.23 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $27.6M | — | ||
| Q4 25 | $32.1M | $27.6M | ||
| Q3 25 | $27.3M | $27.2M | ||
| Q2 25 | $23.2M | $34.4M | ||
| Q1 25 | $17.6M | $32.3M | ||
| Q4 24 | — | $29.4M | ||
| Q3 24 | — | $28.2M | ||
| Q2 24 | — | $16.9M |
| Q1 26 | $-21.9M | — | ||
| Q4 25 | $-13.5M | $-5.0M | ||
| Q3 25 | $-14.2M | $-1.5M | ||
| Q2 25 | $-16.9M | $-287.4K | ||
| Q1 25 | $-28.7M | $1.0M | ||
| Q4 24 | — | $-256.0K | ||
| Q3 24 | — | $700.9K | ||
| Q2 24 | — | $-2.8M |
| Q1 26 | 59.5% | — | ||
| Q4 25 | 59.0% | 23.4% | ||
| Q3 25 | 55.5% | 24.1% | ||
| Q2 25 | 53.8% | 9.5% | ||
| Q1 25 | 50.9% | 21.8% | ||
| Q4 24 | — | 26.9% | ||
| Q3 24 | — | 28.9% | ||
| Q2 24 | — | 13.0% |
| Q1 26 | -47.4% | — | ||
| Q4 25 | -50.2% | -4.9% | ||
| Q3 25 | -62.5% | 0.7% | ||
| Q2 25 | -85.5% | -15.9% | ||
| Q1 25 | -105.7% | 3.7% | ||
| Q4 24 | — | 3.2% | ||
| Q3 24 | — | 7.3% | ||
| Q2 24 | — | -14.4% |
| Q1 26 | -79.3% | — | ||
| Q4 25 | -41.9% | -18.0% | ||
| Q3 25 | -52.1% | -5.7% | ||
| Q2 25 | -72.6% | -0.8% | ||
| Q1 25 | -162.5% | 3.1% | ||
| Q4 24 | — | -0.9% | ||
| Q3 24 | — | 2.5% | ||
| Q2 24 | — | -16.4% |
| Q1 26 | $-0.49 | — | ||
| Q4 25 | $-0.16 | $-0.23 | ||
| Q3 25 | $-0.33 | $-0.08 | ||
| Q2 25 | $-0.39 | $-0.02 | ||
| Q1 25 | $-0.93 | $0.06 | ||
| Q4 24 | — | $-0.01 | ||
| Q3 24 | — | $0.04 | ||
| Q2 24 | — | $-0.16 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $199.5M | — |
| Total DebtLower is stronger | — | $2.6M |
| Stockholders' EquityBook value | $271.2M | $11.6M |
| Total Assets | $304.4M | $75.4M |
| Debt / EquityLower = less leverage | — | 0.22× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $199.5M | — | ||
| Q4 25 | $219.1M | — | ||
| Q3 25 | $228.7M | $1.1M | ||
| Q2 25 | $249.7M | $775.4K | ||
| Q1 25 | $231.5M | $445.4K | ||
| Q4 24 | — | $355.7K | ||
| Q3 24 | — | $588.9K | ||
| Q2 24 | — | $2.1M |
| Q1 26 | — | — | ||
| Q4 25 | — | $2.6M | ||
| Q3 25 | — | $2.6M | ||
| Q2 25 | — | $2.6M | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $2.5M | ||
| Q2 24 | — | $2.6M |
| Q1 26 | $271.2M | — | ||
| Q4 25 | $287.6M | $11.6M | ||
| Q3 25 | $294.8M | $10.1M | ||
| Q2 25 | $301.6M | $11.7M | ||
| Q1 25 | $313.8M | $12.0M | ||
| Q4 24 | — | $10.9M | ||
| Q3 24 | — | $11.2M | ||
| Q2 24 | — | $10.5M |
| Q1 26 | $304.4M | — | ||
| Q4 25 | $328.7M | $75.4M | ||
| Q3 25 | $330.0M | $73.3M | ||
| Q2 25 | $330.0M | $77.4M | ||
| Q1 25 | $338.0M | $82.7M | ||
| Q4 24 | — | $82.7M | ||
| Q3 24 | — | $82.1M | ||
| Q2 24 | — | $82.4M |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.22× | ||
| Q3 25 | — | 0.26× | ||
| Q2 25 | — | 0.22× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.23× | ||
| Q2 24 | — | 0.24× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $-1.7M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $-8.6M | $-1.7M | ||
| Q3 25 | $-8.7M | $1.1M | ||
| Q2 25 | $-13.6M | $-1.6M | ||
| Q1 25 | $-20.0M | $1.7M | ||
| Q4 24 | — | $1.1M | ||
| Q3 24 | — | $3.6M | ||
| Q2 24 | — | $-2.6M |
| Q1 26 | — | — | ||
| Q4 25 | $-10.5M | — | ||
| Q3 25 | $-10.0M | — | ||
| Q2 25 | $-15.4M | — | ||
| Q1 25 | $-20.3M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | — | — | ||
| Q4 25 | -32.8% | — | ||
| Q3 25 | -36.7% | — | ||
| Q2 25 | -66.2% | — | ||
| Q1 25 | -115.1% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | — | — | ||
| Q4 25 | 5.9% | — | ||
| Q3 25 | 4.7% | — | ||
| Q2 25 | 7.7% | — | ||
| Q1 25 | 1.9% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 1.66× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 5.12× | ||
| Q2 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BBNX
Segment breakdown not available.
MSS
| Perishables | $14.4M | 52% |
| Nonperishables | $13.2M | 48% |
